Vimizim, a new approved drug for the treatment of mucopolysaccharidosis type ⅣAHE Xin, XU Jing, XU Jin841-843,856
Comparison of pharmacovigilance information utilization in WHO, Europe, USA and ChinaCONG Luo-luo, BAI Yu-xia, LI Hong-yao, SHAO Ming-li844-848,874
Construction and weight analysis of the risk fault tree of in vitro genotoxicity test in research and development of new drugLI Hui, HUANG Zhe849-856
Performance analysis of traditional Chinese medicine manufacturing industry based on principal component analysisHU Ying-ying, XU Wen, LIU Hui857-860
Analysis of the changes in five-year medicine price levels in Guangdong provinceLIN Qi-min, HAN Sheng, LI Mei-fei, SHI Lu-wen861-864
Analysis of common problems in the impurity research of chemical generics in ChinaLI Xue-mei, ZHANG Zhe-feng865-868
Difference of crystal forms and stability between pantoprazole sodium monohydrate and sesquihydrateQIU Hui, YANG Qing-yun, TONG Yuan-feng, WU Song869-874
Effect of Gaoyuankang capsules on ATP enzyme activity in rats with hypoxic pulmonary hypertensionSUN Chuang-bin, LIU Guo-qing, TAO Zhao-yang, WANG Jian-jun, LI Su-zhi875-877,899
Immunogenicity of Sabin strain inactivated poliomyelitis vaccineSONG Dong-mei, ZHANG Zhong-yang, LU Wei-wei, WEN Zhi-heng, GUO Hui-jie, ZHANG Yue, LI Xiu-ling878-883
Fingerprints and main chemical constituents of Fructus Forsythiae-Fructus Gardeniae herb couple before and after the compositionMENG Xiang-le, LI Hong-wei, HAN Yong-long, LI Yan, WAN Li-li, GUO Cheng884-892,907